HYBIO(SZ:300199)2022-12-08 08:31Group 1: Sales Performance - The sales of customer peptides have grown rapidly this year due to the company's increased expansion into overseas markets [2] - The sales of Teli pressure agents have entered a new stage, with further sales scale expected to emerge [2] Group 2: Technological Advantages - Chengji Pharmaceutical has unique advantages in the domestic medical device and pharmaceutical fields, focusing on "automatic injection technology" [2][3] - The company has developed proprietary products such as cartridge injection pens and combined drug dissolvers, which enhance medication safety and ease of use compared to traditional methods [3] Group 3: Cost Advantages - Chengji Pharmaceutical's geographical location provides cost advantages in land, energy, labor, and management compared to peers in the eastern coastal regions [3] - The acquisition of Chengji Pharmaceutical will facilitate the national layout of the company's production bases, with Shenzhen focusing on high-value-added formulations and Tianshui on low-value-added formulations [3]